Deucravacitinib
CAS: 1609392-27-9
Ref. TM-T14687
| 1mg | 69.00 € | ||
| 5mg | 149.00 € | ||
| 10mg | 269.00 € | ||
| 25mg | 425.00 € | ||
| 50mg | 625.00 € | ||
| 100mg | 892.00 € | ||
| 200mg | 1,205.00 € | ||
| 500mg | 1,784.00 € | ||
| 1ml*10 (DMSO) | 164.00 € |
Estimated delivery in United States, on Wednesday 15 May 2024
Product Information
Name:
Deucravacitinib
Synonyms:
- BMS-986165
CAS:
Description:
Deucravacitinib (BMS-986165) inhibits IL-12/23 and type I IFN pathways[1][2]. BMS-986165 is a highly selective, orally bioavailable allosteric TYK2 inhibitor for the treatment of autoimmune diseases. Which selectively binds to TYK2 pseudokinase (JH2) domain (IC50=1.0 nM) and blocks receptor-mediated Tyk2 activation by stabilizing the regulatory JH2 domain.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
425.46
Formula:
C20H19D3N8O3
Purity:
100%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T14687 Deucravacitinib
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
